Does capmatinib need to be taken long-term?

Capmatinib (Capmatinib) is a drug that targets exon skipping METgene14 Targeted therapeutic drugs for advanced or metastatic non-small cell lung cancer (NSCLC) with jump mutations (METex14) usually require long-term administration. This mainly depends on the patient's condition, treatment effects and doctor's recommendations.

1.Disease control and prevention of recurrence: For NSCLC patients carrying METex14 mutations, the main role of capatinib (capatinib) is to inhibit the proliferation and metastasis of tumor cells, thereby delaying the progression of the disease. Therefore, even after tumors are controlled, patients often require long-term maintenance therapy to prevent recurrence or progression of the disease. Continued drug therapy can help maintain efficacy and prolong patient survival.

2.Clinical practice and research results: According to clinical practice and research results, Capatinib (Capatinib) has shown significant therapeutic effects in NSCLC patients carrying METex14 mutations. However, the disease often progresses again after treatment is stopped. Therefore, doctors usually recommend that patients continue to take capmatinib (capatinib) for a long time to maintain the stability and control of the disease.

3.Individualized treatment plan: Each patient’s condition and treatment response may be different, so the treatment plan needs to be individually adjusted according to the patient’s specific situation. The doctor will decide whether to take capmatinib (capatinib) for a long time based on the patient's condition, treatment effect, adverse reactions and other factors, and adjust the dose.

4.Quality of life and side effect management: Long-term use of drugs may have a certain impact on the patient's quality of life, and some side effects may also occur. Therefore, during long-term treatment, doctors will pay close attention to the patient's physical condition and adverse reactions, and take appropriate management measures to reduce the impact of adverse reactions on the patient's life.

In summary,Capatinib (Capatinib) As a targeted therapy drug, it usually needs to be taken for a long time to maintain the stability and control of the disease and prevent the recurrence or progression of the disease. Patients should closely cooperate with the doctor's monitoring and follow-up during the medication process, and promptly report any symptoms of discomfort to ensure the best treatment effect and quality of life.